defy routine.

Read about what’s going on in our network.

Human Proteome Company Nautilus Biotechnology Raises $76 Million

Nautilus Biotechnology, a company that is pioneering high-throughput and low-cost platform for analyzing and quantifying the human proteome, announced it has raised $76 million

Read more
download (1)
Nautilus emerges with $76M to become the ‘Illumina of proteomics’

Nautilus is uncloaking with a $76 million series B round to do for proteomics—the study of proteins—what companies like Illumnina did for genomics.

Read more
Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome

Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that closed on Monday, May 18, 2020. Nautilus’ total funding now exceeds $100 million.

Read more
Jeff Bezos’s Family Office Bets on Startup Mapping Human Proteins

Nautilus Biotechnology has raised $76 million to help find ways to treat diseases like cancer and multiple sclerosis.

Read more
Jeff Bezos joins $76M round for secretive biotech startup led by Isilon co-founder, Stanford scientist

Nautilus on Thursday announced a $76 million Series B investment round led by Vulcan Capital, the multi-billion-dollar holding company created by the late Microsoft co-founder Paul Allen. Bezos Expeditions, the VC arm of Amazon founder Jeff Bezos, also invested, along with top biotech firm Perceptive Advisors and Defy Partners. Previous backers AME Cloud Ventures, Andreessen…

Read more